跳至主要内容
临床试验/IRCT138904234376N1
IRCT138904234376N1已完成3 期

Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, Lipid Profiles and Hemoglobin Level in Hemodialysis Patients

Mohammad Hossein Dabaghmanesh0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Clinically stable patients within the age range of 18-60.
  • Undergoing maintenance hemodialysis initiated >=3 months previously at a rate of 3 times per week, each session 4 hours.
  • Exclusion criteria: History of cardiovascular event within the previous 12 months, use of cholestrol-lowering agents(statins), Omega-3, Vitamin E, Levothyroxin, and oral contraceptive pills (OCP), infections including HBV, HCV, heart failure class III and IV according to New York Heart Association(NYHA) were also excluded.

排除标准

  • 未提供

研究者

发起方
Mohammad Hossein Dabaghmanesh

相似试验